Abstract:Objective To investigate the application value of FasL,Caspase-8 protein expression and Caspase-8 gene methylation in non-small cell lung cancer(NSCLC). Methods Totally 100 patients with NSCLC were selected,whose cancer tissues and paracancerous tissues(with tumor as the center of radius of 6 cm) were resected,among them;55 cases of pulmonary squamous cell carcinoma,30 cases of lung adenocarcinoma,and 15 cases of squamous cell carcinoma of the lung;50 cases were poorly differentiated carcinoma,30 cases were moderately differentiated carcinoma and 20 cases were highly differentiated carcinoma;there were 65 cases with lymph node metastasis,35 cases without lymph node metastasis,and 100 cases of normal lung tissue were taken as control. Immunohistochemical staining of S-P was used to detect the expression of FasL and Caspase-8 proteins in NSCLC specimens,methylation status of Cas-pase-8 gene in patients with NSCLC was detected by methylation specific polymerase chain reaction(PCR). Results FasL protein was mainly distributed in the serous layer of tumor cells,and a few were spread over the cell membrane. Caspase-8 protein distributed in the cell serous. In NSCLC,FasL protein and Caspase-8 protein in different degree of positive expression,the positive expression rate of FasL protein was significantly higher than those of adjacent tissues and normal tissues(P < 0. 05),the positive expression in lung adenocarcinoma was significantly higher than those in squamous cell carcinoma and squamous cell carcinoma(P < 0. 05),the positive expression rate in poorly differentiated carcinomas was obviously higher than those in moderately differentiated carcinoma and highly dif-ferentiated carcinoma(P < 0. 05),the positive rate of FasL protein in lymph node metastasis was significantly lower than that in non-lymphatic metastasis(P < 0. 05). The positive expression rate of Caspase-8 protein was significantly lower than those of adjacent tis-sues and normal tissues(P < 0. 05),the positive expression in lung adenocarcinoma was significantly lower than those in squamous cell carcinoma and squamous cell carcinoma(P < 0. 05),the positive expression rate in highly differentiated carcinomas was obviously higher than those in moderately differentiated carcinoma and poorly differentiated carcinoma(P < 0. 05),the positive rate of Caspase-8 protein in lymph node metastasis was significantly lower than that in non-lymphatic metastasis(P < 0. 05). The rate of Caspase-8 gene methylation in cancer tissues was significantly higher than that in adjacent tissues and normal tissues,the positive expression in lung adenocarcinoma was significantly higher than in squamous cell carcinoma and squamous cell carcinoma, the positive expression rate in poorly differentiated carcinomas is obviously higher than that of moderately differentiated carcinoma and highly differentiated carcinoma, the positive rate of Caspase-8 gene methylation in lymph node metastasis was significantly lower than that in non-lymphatic metasta-sis ( P < 0. 05 ) . Conclusion High expression of FasL protein and Caspase-8 gene hypermethylation in NSCLC can accelerate the rate of lung cancer cells and tumor cells in the joint,inhibit the activity of immune cells,result in tumor formation without immune region and promote tumor cell division and growth,which become an important cause of early metastasis of adenocarcinoma. The expression of Caspase-8 protein in squamous cell carcinoma is higher,which is the main prognostic factor of squamous cell carcinoma. It is also one of the important indexes to judge the prognosis of NSCLC. Caspase-8 is involved in the evolution of NSCLC,and is closely related to the occurrence,development and metastasis of NSCLC. As an important prognostic factor of NSCLC,Caspase-8 provides an important theoretical basis for the comprehensive and targeted treatment of NSCLC.

Application Value of FasL,Caspase-8 Protein Expression and Caspase-8 Gene Methylation in Non-Small Cell Lung Cancer

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

[Expression of Caspase-8 in Non-Small Cell Lung Cancer and Its Role in Invasion and Metastasis of Lung Cancer A549 Cells].

[The Correlation Between DNA Content and Fas Antigen in Non-Small Cell Lung Cancer].

Expression of Fas/Fasl Gene Protein and Its Chinical Significance in Human Non-small Cell Lung Cancer

Expression and clinical significance of TRIM29, caspase-8 and β-catenin in non-small cell lung cancer

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

[Expression of Phosphorylated Caspase-8 in Non-Small Cell Lung Cancer and the Clinical Implications].

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Predictive value of cysteinyl aspartate-specific protease-8 in predicting non-small cell lung cancer brain metastasis

Analysis of Methylation Status of RASSF1A promoter Region and Transcription Level of Downstream Genes in Non-Small Cell Lung Cancer

[Expression and Clinical Significance of Caspase-3,Survivin and K-Ras in Non-Small Cell Lung Cancer.].

Association of Promoter Methylation with Histologic Type and Pleural Indentation in Non-Small Cell Lung Cancer (NSCLC)

Tissue Microarray Analysis Reveals a Tight Correlation Between Protein Expression Pattern and Progression of Esophageal Squamous Cell Carcinoma

Transcriptional Inactivation of Secreted Frizzled-Related Protein 1 by Promoter Hypermethylation As a Potential Biomarker for Non-Small Cell Lung Cancer.

Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma

Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer

Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer patients

Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma

FAS gene expression, prognostic significance and molecular interactions in lung cancer